AC
BTMD icon

Aristeia Capital’s Biote Corp BTMD Stock Holding History

Aristeia Capital’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,475,000
Closed -$14.6M – 695
2022
Q1 		$14.6M Hold
1,475,000
– – 0.26% 105
2021
Q4 		$14.5M Buy
+1,475,000
New +$14.4M 0.25% 105

Other funds holding BTMD

CM
Cohanzick Management Pleasantville, New York $231M AUM 3.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return

Aristeia Capital's BTMD Position: Q2 2022 in Review

Aristeia Capital sold out of Biote Corp (BTMD) in Q2 2022, closing a stake of 1,475,000 shares — an estimated $14.6M sold.

Aristeia Capital first reported a position in BTMD in Q4 2021 and held it in 2 quarters. The position peaked at $14.6M in Q1 2022. 12 funds tracked by Wall St. Rank hold BTMD as of Q2 2022.

  • Aristeia Capital reported no remaining Biote Corp position as of Q2 2022 after selling out during the quarter.
  • Aristeia Capital sold 1,475,000 Biote Corp shares in Q2 2022, an estimated $14.6M.
  • Aristeia Capital first reported a position in Biote Corp in Q4 2021 and held it in 2 quarters.
  • Aristeia Capital's Biote Corp position peaked at $14.6M in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Biote Corp as of Q2 2022.

Based on Aristeia Capital's 13F filing for Q2 2022, filed 16 Aug 2022.